Menorrhagia and minor bleeding symptoms in women on oral anticoagulation

Journal of Thrombosis and Thrombolysis

Volumn 24, Issue 1, 2007, Pages 39-41

  Själander, Anders ^a   Friberg, Britt ^b   Svensson, Peter ^b   Stigendal, Lennart ^c   Lethagen, Stefan ^b,d  

^a SUNDSVALL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Menorrhagia; Minor bleeding symptoms; Oral anticoagulation; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; EPISTAXIS; FEMALE; FERTILE PERIOD; GINGIVA BLEEDING; HEMATEMESIS; HEMATOMA; HEMATURIA; HUMAN; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; MENORRHAGIA; OCCULT BLOOD; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SIDE EFFECT; SWEDEN; TOOTH EXTRACTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTICOAGULANTS; EPISTAXIS; FEMALE; GINGIVAL DISEASES; HEMORRHAGE; HUMANS; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; TIME FACTORS; TOOTH EXTRACTION;

EID: 34249679559     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-0003-7     Document Type: Article

References (7)

1. Johansson H (1999) Anticoagulant therapy can be safer: An active follow-up and written care programs reduce the number of complications [in Swedish]. Läkartidningen 96:3388-3390
2. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, Dángelo A, Pengo V, Reba N, Moia M, Ciavarella N, Devoto G, Merrettini M, Musolesi S (1994) Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISOCOAT). Lancet 343:687-691
3. Själander A, Engström G, Berntorp E, Svensson P (2003) Risk of hemorrhagic stroke in patients with oral anticoagulation compared to the general population. J Intern Med 254:434-438
4. van Eijkeren M, Christiaens G, Haspels A, Sixma J (1990) Measured menstrual blood loss in women with a bleeding disorder using oral anticoagulant therapy. Am J Obstet Gynecol 62:1261-1263
5. Olsson BS et al (2003) SPORTIF III investigators stroke prevention with the oral direct thrombin inhibitor ximegalatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomized controlled trial. Lancet 362:1691-1698
6. Wallentin L, Wilcox RG, Weaver WD, Emanuelsson H, Goodvin A, Nystrom P, Bylock A (2003) Oral ximegalatran for secondary prophylaxis after myocardial infarction: The ESTEEM randomized controlled trial. Lancet 362:789-797
7. Schulman S, Wahlander K, Lundstrom T, Clason SB, Eriksson H (2003) THRIVE III Investigators. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximegalatran. N Eng J Med 349:1713-1721